Liver disease severity can be assessed through various parameters, such as albumin, bilirubin and prothrombin time and multiple scores have been used for that purpose, including the Child-Pugh score, Model for End-stage Liver Disease (MELD) with its variations and Albumin-Bilirubin (ALBI) score (49, 50). This evidence concerns the gene F2 and liver disorder.